Decades ago, in 1976, New Jersey citizens decided that Atlantic City should be able to run casinos. This actually helped save the city from going bankrupt. Now, it has been four decades, and the city is once more in danger of going bankrupt. That is why people are wondering whether or not Atlantic City should be the only place in New Jersey to allow the legal sale of marijuana. State Assemblyman Reed Gusciora (D-Mercer) stated that he plans to introduce a measure this week that would allow voters to choose whether or not they support legalizing marijuana by adults 21 or older in Atlantic City.

The Attorney General’s Office would manage AC’s cannabis market the same way that it does casinos, the bill reports. Fifty percent of the proceeds from twenty percent sales tax would be given to the federal government to hold. Thirty percent of that would fund road projects while ten percent would pay for women’s health programs as well as drug enforcement attempts. Albeit he is an advocate of legalization and decriminalization, Gusciora states that the main goal of this bill is to generate money for Atlantic City, which has seen fifty percent of its casino revenues fade away since four casinos have already closed.

“It’s a challenge if they can even meet the milestones the state has set up,” Gusciora stated. “The thing they need is to generate real dollars — something Atlantic City can’t do on its own, and generate more tourists. Right now, there are too many tourists who decide to go to Delaware, the Poconos, and New York.” Voters in Nevada will decide on November 8th whether recreational cannabis should be legalized. Gusciora hopes his measure will pass the legislature before the summer recess begins on June 30th, “to keep Atlantic City competitive with Las Vegas,” he concluded.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

1 Biotech Stock That Could Have Investors Looking At A Billion-Dollar Opportunity

The recent $12 billion acquisition of Kite Pharma, Inc. by big-pharma giant,…